Psychedelics and Psychedelic-Assisted Psychotherapy.
Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (10)
- Prevalence and Correlates of Past-Year Psilocybin Use in the United States 2026-11-01 · Expand citations
- Psilocybin in Treatment-Resistant Depression: Weighing Rapid Antidepressant Effects Against Uncertain Durability 2026-10-19 · Expand citations
- Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults 2026-10-01 · Expand citations
- Cardiovascular safety of psilocybin in psychiatric practice: a narrative review 2026-08-01 · Expand citations
- Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms 2026-07-01 · Expand citations
- Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis 2026-06-15 · Expand citations
- Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression 2026-06-01 · Expand citations
- The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes 2026-04-21 · Expand citations
- Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin 2026-04-01 · Expand citations
- Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies 2026-03-19 · Expand citations